Tag: MEN2

Multiple Endocrine Neoplasia (MEN) Patient and Family Seminar in Chicago

Multiple Endocrine Neoplasia 1 and 2 patients and their families are invited to a free, half-day education seminar on Saturday, March 22, 2014, presented by the Lurie Cancer Center of Northwestern University in Chicago, Illinois and American Multiple…

Multiple Endocrine Neoplasia (MEN) Type 1 Seminar Scheduled for June 2012 at Mayo Clinic

MEN, carcinoid, and neuroendocrine cancer patients, family members, caregivers, advocacy groups, physicians, and healthcare professionals are invited to attend the Multiple Endocrine Neoplasia Type 1 Seminar presented by American Multiple Endocrine…

Phase II Clinical Trial Recruiting Carcinoid and Related Neuroendocrine Tumor Patients

Participants are being recruited for a Phase II clinical study of capecitabine and temozolomide (CAPTEM) for neuroendocrine cancer patients with progressive, differentiated, metastatic neuroendocrine tumors (NETs). Patients with carcinoid,…

Multiple Endocrine Neoplasia (MEN) Seminar Scheduled for September 2011 at Mayo Clinic

SPECIAL NOTE:  This seminar has been cancelled but may be rescheduled at a later date in a different format.  We will post any updates we  receive.

__________________________________________________________________

MEN, carcinoid, and neuroendocrine…